Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: BIS Research | PRODUCT CODE: 1067359

Cover Image

PUBLISHER: BIS Research | PRODUCT CODE: 1067359

Plasma Medicine Market - Strategies and Implementation

PUBLISHED:
PAGES: 55 Pages
DELIVERY TIME: 1-5 business days
SELECT AN OPTION
PDF and Excel (1-3 User License)
USD 4000
PDF and Excel (Global License)
USD 6400

Add to Cart

“BIS Research Study Highlights Plasma Medicine Market: Strategies and Implementation.”

Market Report Coverage - Plasma Medicine

Market Segmentation

  • Industry Overview
  • An Insight on Plasma Medicine
  • Applications (Therapeutic Applications, Biological Decontamination)
  • Risk Estimation
  • Basic Cell Biology of Plasma-Supplied Wound Healing
  • Challenges and Perspectives of Plasma Medicine
  • Company's strategy for Implementation of Plasma Medicine (North America, Europe)
  • SWOT Analysis of Plasma Medicine
  • The Making of Plasma Medicine
  • Recent Plasma Therapy News and Information

Key Companies Profiled

US Medical Innovations, Plasmacure, neoplas med GmbH, Plasma Surgical, Coldplasmatech GmbH, terraplasma medical GmbH.

Key Questions Answered in this Report:

  • What are the strategies and implementation of the plasma medicine industry which can affect the future perception for the market?
  • How is the market expected to grow during the upcoming period of time (5-10 years)?
  • How does plasma medicine evolve?
  • What are the major applications for plasma medicine?
  • What are the emerging trends in technology within the plasma medicine market?
  • What are the key developmental strategies implemented by the major players to sustain in the competitive market?
  • What are the key regulatory implications in developed and developing regions for the plasma medicine market?
  • Who are the leading players with significant offerings to the plasma medicine market? What is the current market dominance for each of these leading players?
  • What are the major technologies employed in the plasma medicine market? Which is the dominating technology?
  • Who are the primary end-users of the plasma medicine market?
  • Who are the key manufacturers in the plasma medicine market, and what are their contributions? Also, what is the growth potential of each major plasma medicine market manufacturer?
  • What is the scope of the plasma medicine market in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World? Which plasma medicine technology and end user dominate these regions?
  • What are the emerging trends in the plasma medicine market? How are these trends revolutionizing the treatment procedure?
  • Which technologies are anticipated to break through the plasma medicine market regime?
  • Which companies are anticipated to be highly disruptive in the future and why?
  • Which regulatory procedures are required to unify the approval process for the emerging plasma medicine market? How will these enhance the reimbursement scenario?
  • What are the gaps in regularizing plasma medicine market adoption in regular healthcare routines? How are these gaps being tackled?

Market Overview

Plasma medicine is a growing field combining plasma physics, biology, and clinical medicine and has an impact in several important areas in therapeutic patient care, combining plasma physics, biology, and clinical medicine. Earlier, plasmas in medicine were used in non-contact hemostasis and electrosurgery for cautery, while presently, non-thermal plasmas have attained widespread use in medicine due to their effectiveness and compatibility with biological systems. The most active areas of plasma technology applications are in the inactivation of pathogens, wound treatment, treatment of skin disorders, tissue regeneration, and sterilization. There are various ways of generating plasmas for use in medical applications, such as plasma jets, dielectric barrier discharges, capacitively or inductively coupled discharges, and microplasmas. These technologies transform systems that use room air, gases, and other liquids at low temperatures. Additionally, several commercial products have been overviewed in light of the technology utilized, health care problems being solved, and clinical trial results.

This strategic report provides a multidimensional view of the strategic evolution of the ongoing plasma medicine initiatives. The purpose of the study is to gain a holistic view of the active plasma medicine projects implemented in several countries. The report contains the analysis of various such as recent trends, technological advancements, reimbursement scenario, and international level initiatives across the globe influencing the adoption of plasma medicine. The scope of this report is centered upon conducting a detailed study of the strategies, best R&D practices across the globe, and understanding the focus of eminent stakeholders contributing to augmenting the growth of the plasma medicine initiatives.

Product Code: BHP1183SA

Table of Contents

1 Strategies and Implementation

  • 1.1 Industry Overview
    • 1.1.1 Plasma Medicine: Overview
    • 1.1.2 Timeline: Evolution of the Plasma Medicine
  • 1.2 An Insight on Plasma Medicine
  • 1.3 Applications
    • 1.3.1 Therapeutic Applications
    • 1.3.2 Biological Decontamination
  • 1.4 Risk Estimation
  • 1.5 Basic Cell Biology of Plasma-Supplied Wound Healing
  • 1.6 Challenges and Perspectives of Plasma Medicine
  • 1.7 Strategies for Implementation of Plasma Medicine (by Region)
    • 1.7.1 North America
      • 1.7.1.1 U.S.
        • 1.7.1.1.1 U.S. Medical Innovations
        • 1.7.1.1.2 Products Offered by the Company
        • 1.7.1.1.3 The Canady Cold Plasma Procedure
    • 1.7.2 Europe
      • 1.7.2.1 Netherlands
        • 1.7.2.1.1 Plasmacure
        • 1.7.2.1.2 Product Offered by the Company
      • 1.7.2.2 Germany
        • 1.7.2.2.1 neoplas med GmbH
          • 1.7.2.2.1.1 Product Offered by the Company
          • 1.7.2.2.1.2 Treatment of Chronic Wounds: Mode of Action of the kINPen MED
        • 1.7.2.2.2 terraplasma medical GmbH
          • 1.7.2.2.2.1 Product offered by the Company
        • 1.7.2.2.3 coldplasmatech GmbH
          • 1.7.2.2.3.1 Product offered by the Company:
          • 1.7.2.2.3.2 CPT Treatment
      • 1.7.2.3 Georgia
        • 1.7.2.3.1 Plasma Surgical
          • 1.7.2.3.1.1 Product Offered by the Company
  • 1.8 SWOT Analysis of Plasma Medicine
    • 1.8.1 Strengths
    • 1.8.2 Weaknesses
    • 1.8.3 Opportunities
    • 1.8.4 Threats
  • 1.9 The Making of Plasma Medicine
    • 1.9.1 Europe
      • 1.9.1.1 Germany
        • 1.9.1.1.1 Trends in German Innovation Policy
        • 1.9.1.1.2 Plasma Medication is Becoming More Prominent Method of Treatment
        • 1.9.1.1.3 Strategic and Organizational Dilemmas and Management Issues: Trust Formation, Strategy Implementation, and Stakeholder Management
        • 1.9.1.1.4 Policy Implications
  • 1.1 Recent Plasma Therapy News and Information
    • 1.10.1 As a Potential Treatment for Diabetic Foot Ulcers, Cold Plasma Ionised Gas Could Also Kill COVID-19 Virus Indoors
    • 1.10.2 Cold Plasma against the Coronavirus
    • 1.10.3 Immunotherapy for Melanoma Could Be Improved by Using a Cold Plasma Patch
  • 1.11 Competitive Benchmarking
    • 1.11.1 US Medical Innovations
      • 1.11.1.1 Company Overview
      • 1.11.1.2 Role of US Medical Innovations in the Plasma Medicine Market
      • 1.11.1.3 SWOT Analysis
    • 1.11.2 Plasmacure
      • 1.11.2.1 Company Overview
      • 1.11.2.2 Role of Plasmacure in the Plasma Medicine Market
      • 1.11.2.3 SWOT Analysis
    • 1.11.3 neoplas med GmbH
      • 1.11.3.1 Company Overview
      • 1.11.3.2 Role of neoplas med GmbH in the Plasma Medicine Market
      • 1.11.3.3 SWOT Analysis
    • 1.11.4 Plasma Surgical
      • 1.11.4.1 Company Overview
      • 1.11.4.2 Role of Plasma Surgical in the Plasma Medicine Market
      • 1.11.4.3 SWOT Analysis
    • 1.11.5 Coldplasmatech GmbH
      • 1.11.5.1 Company Overview
      • 1.11.5.2 Role of coldplasmatech GmbH in the Global Plasma Medicine Market
      • 1.11.5.3 SWOT Analysis
    • 1.11.6 terraplasma medical GmbH
      • 1.11.6.1 Company Overview
      • 1.11.6.2 Role of terraplasma medical GmbH in the Plasma Medicine Market
      • 1.11.6.3 SWOT Analysis
Product Code: BHP1183SA

List of Figures

  • Figure 1: Plasma Medicine Market: Segmentation
  • Figure 2: Fields of Biomedical Applications of Physical Plasma
  • Figure 3: Important Turning Points in the Evolution of Low-Temperature Plasma Medicine
  • Figure 4: Basic Concept of Plasma Supported Wound Healing
  • Figure 5: Departments of the Company
  • Figure 6: Estimated New Cancers
  • Figure 7: Effective Components of Cold Plasma
  • Figure 8: Research Areas of the Product
  • Figure 9: SWOT Analysis of CAP Technology
  • Figure 10: US Medical Innovations: Product Portfolio
  • Figure 11: US Medical Innovations: SWOT Analysis
  • Figure 12: Plasmacure: Product Portfolio
  • Figure 13: Plasmacure: SWOT Analysis
  • Figure 14: neoplas med GmbH: Product Portfolio
  • Figure 15: neoplas med GmbH: SWOT Analysis
  • Figure 16: Plasma Surgical: Product Portfolio
  • Figure 17: Plasma Surgical: SWOT Analysis
  • Figure 18: Coldplasmatech GmbH: Product Portfolio
  • Figure 19: Coldplasmatech GmbH: SWOT Analysis
  • Figure 20: terraplasma medical GmbH: Product Portfolio
  • Figure 21: terraplasma medical GmbH: SWOT Analysis
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!